Our work featured in Chemistry & Industry
Our research on Chestnut is featured in the September 2015 issue of Chemistry & Industry! The article “Chestnut disarms superbug” can be found in the news section.
Our research on Chestnut is featured in the September 2015 issue of Chemistry & Industry! The article “Chestnut disarms superbug” can be found in the news section.
Excerpt from the piece: Cutting Off Communication Researchers have found a plant extract that halts Staphylococcus aureus infections without promoting resistance. Will this lead to a new way to treat bacterial infections? Read more… http://www.biotechniques.com/news/Cutting-Off-Communication/biotechniques-360385.html#.VfGkmfm2Vsv
We are so excited to have had press coverage on our most recent collaborative paper with the Horswill group! Stay tuned to our Twitter feed (@QuaveEthnobot) for news on the discovery. The full original article is available free via Open Access at PLoS ONE. Here are some links to the…
A new publication is out on a collaborative project between the Quave Lab (Emory University) and Horswill Lab (University of Iowa). Their latest study reports on the anti-virulence activity of compounds from Chestnut leaves. The extract blocks virulence by switching off the pathways necessary for the production of toxins. The…
Press release on new discovery: Chestnut leaves yield extract that disarms deadly staph bacteria http://phys.org/news/2015-08-chestnut-yield-deadly-staph-bacteria.html
Dr. Quave is honored to be delivering the keynote lecture at the 2015 Atkins Medicinal Garden Walk and Lecture at the University of Illinois at Chicago College of Pharmacy on July 17th! Guided tours of the gardens will be offered by UIC’s ethnobotanists. The Lecture will be held at noon.…
Flipping the switch: tools for detecting small molecule inhibitors of staphylococcal virulence Drs. Quave and Horswill have co-authored a review on different laboratory tools and approaches that can be used to detect small molecule inhibitors of Staphylococcus aureus virulence. Virulence inhibitors could be used in the future as adjuvants to…
July 20th, 2012. PhytoTEK LLC, the start-up biotech company co-founded by Dr. Cassandra Quave and Mr. Sahil Patel, was awarded a Georgia Research Alliance (GRA) Venture Lab Phase IA award in the amount of $25,000 for the proposal “Anti-infectives for Companion Animals”. The aims of this project are to pursue…
A grant proposal entitled “Mechanistic Studies on Staphylococcal Quorum Quenching Natural Products” has been selected for funding under the R01 mechanism from the National Center for Complementary and Alternative Medicine at the US National Institutes of Health. The five year research project, totaling $1.829 million dollars, will be led by…